Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
- PMID: 20205721
- PMCID: PMC2837855
- DOI: 10.1186/1471-2458-10-111
Antiretroviral treatment adherence among HIV patients in KwaZulu-Natal, South Africa
Abstract
Background: Successful antiretroviral treatment is dependent on sustaining high rates of adherence. In the southern African context, only a handful of studies (both quantitative and qualitative) have looked at the determinants including a health behaviour theory of adherence to antiretroviral therapy. The aim of this study is to assess factors including the information, motivation and behavioural skills model (IMB) contributing to antiretroviral (ARV) adherence six months after commencing ARVs at three public hospitals in KwaZulu-Natal, South Africa.
Methods: Using systematic sampling, 735 HIV-positive patients were selected prior to commencing on ART from outpatient departments from three hospitals and followed-up at six months and interviewed with a questionnaire.
Results: A good proportion of patients were found to be adherent using both adherence instruments (visual analog scale = VAS 82.9%; Adult AIDS Clinical Trials Group = AATCG 70.8%). After adjusting for significant socio-economic variables, both the VAS and the dose, schedule and food adherence indicator found levels of adherence amongst urban residents to be almost 3 times greater than that of rural residents. After adjusting for health-related variables, for both indicators better adherence was associated with low depression and poorer adherence was associated with poor environmental factors. Adjusted odds ratios for adherence when taking into account different behavioural variables were for both adherence indicators, discrimination experiences were associated with lower adherence, and higher scores in adherence information and behavioural skills were associated with higher adherence. For the VAS adherence indicator, higher social support scores were associated with higher adherence. For the dose, schedule and food adherence indicator, using herbal medicines for HIV was associated with lower adherence.
Conclusion: For the patients in this study, particularly those not living in urban areas, additional support may be needed to ensure patients are able to attend appointments or obtain their medications more easily. Adherence information and behavioural skills as part of the IMB model should be strengthened to improve adherence. Further psychological support is also required and patients' perceived need for ARTs should be routinely assessed.
Similar articles
-
Social support, disclosure and stigma and the association with non-adherence in the six months after antiretroviral therapy initiation among a cohort of HIV-positive adults in rural KwaZulu-Natal, South Africa.AIDS Care. 2019 Jul;31(7):875-884. doi: 10.1080/09540121.2018.1549720. Epub 2018 Nov 25. AIDS Care. 2019. PMID: 30472889 Free PMC article.
-
Antiretrovirals and the use of traditional, complementary and alternative medicine by HIV patients in Kwazulu-Natal, South Africa: a longitudinal study.Afr J Tradit Complement Altern Med. 2011;8(4):337-45. doi: 10.4314/ajtcam.v8i4.1. Epub 2011 Jun 1. Afr J Tradit Complement Altern Med. 2011. PMID: 22654209 Free PMC article.
-
Traditional complementary and alternative medicine and antiretroviral treatment adherence among HIV patients in Kwazulu-Natal, South Africa.Afr J Tradit Complement Altern Med. 2009 Dec 30;7(2):125-37. Afr J Tradit Complement Altern Med. 2009. PMID: 21304624 Free PMC article.
-
Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.BMC Public Health. 2018 Jun 27;18(1):805. doi: 10.1186/s12889-018-5651-y. BMC Public Health. 2018. PMID: 29945601 Free PMC article.
-
Exploring 'generative mechanisms' of the antiretroviral adherence club intervention using the realist approach: a scoping review of research-based antiretroviral treatment adherence theories.BMC Public Health. 2017 May 4;17(1):385. doi: 10.1186/s12889-017-4322-8. BMC Public Health. 2017. PMID: 28472938 Free PMC article.
Cited by
-
Antiretroviral therapy initiation and adherence in rural South Africa: community health workers' perspectives on barriers and facilitators.AIDS Care. 2016 Aug;28(8):982-93. doi: 10.1080/09540121.2016.1164292. Epub 2016 Apr 4. AIDS Care. 2016. PMID: 27043077 Free PMC article.
-
Depression among Adult HIV/AIDS Patients Attending ART Clinics at Aksum Town, Aksum, Ethiopia: A Cross-Sectional Study.Depress Res Treat. 2019 Feb 3;2019:3250431. doi: 10.1155/2019/3250431. eCollection 2019. Depress Res Treat. 2019. PMID: 30863637 Free PMC article.
-
Viral Load Suppression after Enhanced Adherence Counseling and Its Predictors among High Viral Load HIV Seropositive People in North Wollo Zone Public Hospitals, Northeast Ethiopia, 2019: Retrospective Cohort Study.AIDS Res Treat. 2020 Apr 21;2020:8909232. doi: 10.1155/2020/8909232. eCollection 2020. AIDS Res Treat. 2020. PMID: 32373359 Free PMC article.
-
Perceived Barriers to HIV Care and Viral Suppression Comparing Newly Diagnosed Women Living with HIV in Rural Uganda with and without a History of Intimate Partner Violence.J Interpers Violence. 2022 Oct;37(19-20):NP17133-NP17156. doi: 10.1177/08862605211028284. Epub 2021 Jun 26. J Interpers Violence. 2022. PMID: 34176367 Free PMC article. Clinical Trial.
-
Patient-level predictors of detection of depressive symptoms, referral, and uptake of depression counseling among chronic care patients in KwaZulu-Natal, South Africa.Glob Ment Health (Camb). 2020 Jul 21;7:e18. doi: 10.1017/gmh.2020.11. eCollection 2020. Glob Ment Health (Camb). 2020. PMID: 32913657 Free PMC article.
References
-
- Kredo T, Walt J Van der, Siegfried N, Cohen K. Therapeutic drug monitoring of antiretrovirals for people with HIV. Cochrane Database Systematic Review. 2009;10(3):CD007268. - PubMed
-
- Kuhn L, Semrau K, Ramachandran S, Sinkala M, Scott N, Kasonde P, Mwiya M, Kankasa C, Decker D, Thea D, Aldrovandi G. Mortality and virologic outcomes after access to antiretroviral therapy among a cohort of HIV-infected women who received single-dose nevirapine in Lusaka, Zambia. J Acquir Immune Defic Syndr. 2009;10(1):132–136. doi: 10.1097/QAI.0b013e3181ab6d5e. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical